BML-278
-
Catalog number2379-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_nameN-Benzyl-3,5-dicarbethoxy-4-phenyl-1,4-dihydropyridine
-
DescriptionCell-permeable. A structurally novel activator of SIRT1 (EC₅₀ = 1 µM). Displays selectivity over SIRT2 and 3 (EC₅₀ = 25 and 50 µM respectively).
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₄H₂₅NO₄
-
Molecular Weight391.46
-
Cell PermeableYes
-
Purity≥98% by TLC
-
SolubilitiesDMSO (~ 5 mg/ml)
-
HandlingProtect from light and moisture
-
Tag LineA SIRT1 activator
-
Storage Condition-20 ̊C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
SMILESO=C(OCC)C1=CN(CC2=CC=CC=C2)C=C(C(OCC)=O)C1C3=CC=CC=C3
-
InChiInChI=1S/C24H25NO4/c1-3-28-23(26)20-16-25(15-18-11-7-5-8-12-18)17-21(24(27)29-4-2)22(20)19-13-9-6-10-14-19/h5-14,16-17,22H,3-4,15H2,1-2H3
-
InChi KeyJOHFECBOWRGWJZ-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Gene symbolFLNB
-
Short nameBML-278
-
Alternative nameBML-278
-
Gene info
-
Identity
-
Gene
-
Long gene namefilamin B
-
Synonyms gene
-
Synonyms gene name
- filamin B, beta (actin binding protein 278)
- Larsen syndrome 1 (autosomal dominant)
- filamin B, beta
-
Synonyms
-
Synonyms name
-
GenBank acession
-
Locus
-
Discovery year1997-06-20
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- Filamins
-
VEGA ID